Niels Nielsen

The Confédération des Industries Agro Alimentaires de l'UE is based in Brussels, BE and represents the European food and drink industry, which is the largest manufacturing sector in the EU in terms of turnover and employment. To be the standard for food sustainability, the EU must commit more to research and innovation (R&I). The Belgian company focuses on promoting the industry's interests to European and international institutions, contributing to a framework addressing food safety and science, nutrition and health, environmental sustainability, and competitiveness. The private company provides information on food processing, additives, contaminants, food safety, food security, environment, health, nutrition, and packaging. The EU food and drink industry generates millions of jobs and plays an integral part in driving the EU economy. Only with ambitious and science-based regulation can we make the R&I capital of the world.

Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark.

Novozymes BioloAg A/S provides research and development for biotechnology products and processes. It participates in The BioAg Alliance to commercialize BioAg assets and competencies within microbial research, development, and production. The company was founded on October 22, 2007 and is headquartered in Bagsvaerd, Denmark.

Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.

Protera SAS manufactures protein-based ingredients to address critical challenges in food, agriculture, the environment, and human health. Its products include Guard, Sense, antioxidant proteins, and foaming and emulsifying proteins. The company was founded by Leonardo Álvarez and Francia Navarrete and is headquartered in Neuilly-sur-Seine, France.

Sara Lee Food & Beverage manufactures and supplies food products. The company offers frozen cakes, pies, cheesecakes, packaged deli meats, cheeses and baked goods. It offers products under the brand names Holsum, Earth Grains, Mother's Healthy Choice and IronKids. Sara Lee Food & Beverage is headquartered in Downers Grove, IL

K/S Scandinavian Property Investment 11 is a Danish company that rents commercial real estate properties. The private company is based in Kongens Lyngby, Denmark.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

Froneri International Ltd. manufactures and sells ice creams, lollipops and other frozen confectionery products. It offers ice cream tubs, multi-packs of ice cream cones, and ice lollies (popsicles), sticks and desserts. The company was founded by James Lambert in 1985 and is headquartered in Northallerton, the United Kingdom.

J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain.

Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk.

Angulas Aguinaga SA manufactures and distributes pre-cooked meals and packaged seafood products. It offers frozen prawns, octopus, ocean tails, and sticks used in seafood salads, shish kebabs and sandwiches. The firm operates under the brand names La Gula del Norte, Krissia, Pulpo, and Angulas Aguinaga. The company was founded in 1974 and is headquartered in Irura, Spain.

Fero Foundation is an Indonesian company that engages in oncological research activities.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million.

AXA Belgium Finance (NL) BV provides insurance, welfare, savings, loans and asset management products and services. It is a private limited liability company, incorporated under the laws of the Netherlands. The company supply products and services in the fields of insurance, welfare, savings, loans and asset management. AXA Belgium Finance is headquartered in Breda, the Netherlands.

Part of Spring TopCo DK ApS, Spring MidCo DK ApS is an investment holding company. Spring MidCo DK ApS is located in Denmark.

Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands.

A-Mansia Biotech provides business services. The company was founded on October 11, 2016 and is headquartered in Ottignies-Louvain-la-Neuve, Belgium.